Dispatch Biotherapeutics

TILT Biotherapeutics

This company develops oncolytic viral immunotherapies to treat patients with solid tumours by enhancing immune system responses against cancer cells.

Bicara Therapeutics

This biotechnology company develops dual-action biologics to treat patients with solid tumours by targeting the tumour microenvironment.

Tango Therapeutics

This biotechnology company develops precision oncology medicines targeting genetic vulnerabilities in cancer cells for patients with solid tumours.

Theolytics

The company develops oncolytic viral immunotherapies for patients with solid tumours.

Oncolytic virus therapies

This clinical-stage biotechnology company develops engineered oncolytic virus therapies for cancer patients to destroy tumours and stimulate the immune system.

Bioarchitech

This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.

D3 Bio

This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.